GlassScriptPhysician profile
Nathan Leslie Guerette
NPI 1942230040
$19,664.01
in general payments reported to CMS, 2019-2025
22 companies · $345 in 2025
The $345 reported for 2025 was less than what a typical Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) provider received nationally (typical 2025 total: $413).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,808 · 2020: $362 · 2021: $13K · 2022: $1,385 · 2023: $394 · 2024: $1,495 · 2025: $345.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,889 · Travel and Lodging: $330 · Gift: $14.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,888.62 |
| Travel and Lodging | $329.96 |
| Gift | $14.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $6,453.61 | 2021-2023 | Saffron |
| Caldera Medical, INC | $5,796.49 | 2021 | |
| Intuitive Surgical, INC. | $3,403.35 | 2019-2024 | |
| Momentis Surgical INC. | $1,094.00 | 2022 | |
| Medtronic, INC. | $517.36 | 2021-2025 | Interstim |
| Abbvie INC. | $516.31 | 2022-2025 | |
| Axonics, INC. | $504.84 | 2020-2023 | Axonics |
| Medtronic USA, INC. | $355.27 | 2019-2020 | |
| Allergan, INC. | $203.00 | 2019-2021 | |
| Boston Scientific Corporation | $196.60 | 2024-2025 | Upsylon |
| Astellas Pharma US INC | $169.89 | 2019-2024 | Veozah, Myrbetriq |
| Pfizer INC. | $97.82 | 2019-2022 | |
| Therapeuticsmd, INC. | $60.72 | 2019-2020 | |
| Amag Pharmaceuticals, INC. | $60.14 | 2019 | |
| Musculoskeletal Transplant Foundation INC. | $56.13 | 2023 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Community Blood Center | $35.06 | 2024 | |
| Myovant Sciences INC. | $34.84 | 2021 | |
| Ethicon US, LLC | $33.54 | 2022 | |
| Laborie Medical Technologies Corp. | $27.64 | 2025 | Optilume Bph Drug Coated Balloon Catheter |
| Provepharm INC. | $19.28 | 2025 | Bludigo |
| Coopersurgical, INC. | $14.32 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.80 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathan Guerette listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.